Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells

Added 151 days ago (02.07.2021)
Authors: Shi, Y., Dolan, M., Mastri, M., Hill, J. W., Dommer, A., Benzekry, S., Eng, K., Ebos, J. M. L.
Source: bioRxiv
Read article